Oramed Pharmaceuticals Inc.
Veridion Score
Composite trend over time
Why is ORMP moving today?
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for ORMP.
ORMP insider activity
Oramed Pharmaceuticals Inc.
No multi-insider buying cluster in the last 90 days
Net selling: -$1.6M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2026-03-30 | KIDRON NADAV | Insider | sell | $3.31 | 44,818 | 3,422,243 | $148K | SEC Form 4 |
| 2026-03-31 | 2026-03-30 | Kidron Miriam | Insider | sell | $3.31 | 435,084 | 1,133,138 | $1.4M | SEC Form 4 |
ORMP contract awards, year to date.
Public federal awards linked to this ticker.
ORMP lobbying filings, year to date.
Registered lobbying filings matched to Oramed Pharmaceuticals Inc..